- Warhammer maker Games Workshop enters London's top stocks index
- Iran Nobel winner released for three weeks, 'unconditional' freedom urged
- Red Cross marks record numbers of humanitarians killed in 2024
- Johnson's Grand Slam 'no threat', says World Athletics boss Coe
- Qatar's emir and UK's Starmer talk trade as state visit ends
- Cuba suffers third nationwide blackout in two months
- Russia, Ukraine to send top diplomats to OSCE summit in Malta
- Spanish royals to attend memorial service for flood victims
- LPGA, USGA new policy requires female at birth or pre-puberty change
- Stick to current climate change laws, US tells top UN court
- British Museum chief says Marbles deal with Greece 'some distance' away
- Pope Francis receives electric popemobile from Mercedes
- Gaza civil defence: thousands flee Israeli strikes, evacuation calls
- Trump names billionaire private astronaut as next NASA chief
- Pidcock to leave INEOS Grenadiers at end of season
- Seoul stocks weaken, Paris advances despite political turmoil
- South America summit hopes to seal 'historic' trade deal with EU
- DAZN awarded global TV rights for Club World Cup
- Top executive shot dead outside New York hotel
- Vaping while still smoking unlikely to help quitters: study
- British Museum chief says Parthenon Marbles deal with Greece 'some distance' away
- 'Creating connections': Arab, African filmmakers gather at Morocco workshops
- Iran frees Nobel winner for three weeks, sparking calls for 'permanent' release
- Brazil's Minas cheese gets added to UNESCO list
- Top US executive shot dead in New York City: media
- Trump's nominee to run Pentagon hangs by a thread
- GM announces more than $5 bn hit to earnings in China venture
- World chess champ Ding, teen challenger tied past halfway mark
- Georgia police raid opposition offices as PM vows to curb protests
- S. Korea opposition begins push to impeach president
- Syrian army fights rebel offensive with counterattack
- France court upholds Polanski acquittal in defamation case
- UK bans daytime TV ads for cereals, muffins and burgers
- Palace's Guehi to face no formal action over 'Jesus' message on rainbow armband
- UK faces trade balancing act with Trump, EU
- Iran releases Nobel Peace laureate Mohammadi on medical leave: lawyer
- UNESCO grants heritage status to Aleppo soap as Syria war flares
- Ghana's illegal mining boom seeps into presidential election
- Inconsistent Spurs 'progressing in all aspects': Postecoglou
- France's Orano says Niger junta controls uranium firm
- Seoul stocks weaken, Paris edges up tracking political turmoil
- China reports warmest autumn since records began
- French marine park to close over law banning killer whale shows
- Thousands march demanding S. Korea president resign over martial law debacle
- Taiwan romance novelist Chiung Yao dies at 86
- In Angola, Biden promises to invest differently to China
- Syrian army launches counteroffensive against rebels
- Evenepoel says 'long journey' ahead after postal van collision
- South Korea's day of rage as Yoon's martial law founders
- UK police question killer nurse Letby over further baby deaths
RIO | -0.16% | 63.41 | $ | |
BTI | 0.44% | 37.194 | $ | |
BP | -1.06% | 29.141 | $ | |
CMSC | 0.15% | 24.596 | $ | |
NGG | -1.14% | 62.26 | $ | |
GSK | -1.06% | 34.535 | $ | |
CMSD | 0.45% | 24.42 | $ | |
SCS | -0.9% | 13.4 | $ | |
RYCEF | 1.46% | 7.55 | $ | |
AZN | -2.02% | 66.705 | $ | |
BCC | -0.53% | 145.665 | $ | |
JRI | -0.89% | 13.42 | $ | |
BCE | -1.83% | 26.82 | $ | |
VOD | -0.28% | 8.805 | $ | |
RBGPF | -1.64% | 61 | $ | |
RELX | 0.91% | 47.915 | $ |
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
M.Ouellet--BTB